BIOLASE, Inc. (OTCQB:BIOL) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Todd Kehrli – Investor Relations-EVC Group John Beaver – President and Chief Executive Officer Jennifer Bright – Vice President-Finance Conference Call Participants Kyle Bauser – Colliers Bruce Jackson – Benchmark Company Matt Bullock – Maxim Group Ed Woo – Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2021 Third Quarter Financial Results Conference Call. Today’s conference is bei ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36385 BIOLASE, INC. (Exact name of registrant as specified in its charter) ...

BIOLASE, Inc. (OTCQB:BIOL) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Todd Kehrli - IR, EVC Group John Beaver - President and Chief Executive Officer Jennifer Bright - Vice President, Finance Conference Call Participants Kyle Bauser - Colliers Securities Matt Bullock - The Maxim Group Bruce Jackson - The Benchmark Company Ed Woo - Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2021 Second Quarter Financial Results Conference Call. Today's conference is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act Title of each class Trading symbol(s) Name of each exchange on which registered Common stock at par value $0.001 per share BIOL The NASDAQ Stock Market LLC (NASDAQ Capital Market) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) O ...

BIOLASE, Inc. (OTCQB:BIOL) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Todd Kehrli - IR, EVC Group John Beaver - President and Chief Executive Officer Jennifer Bright - Vice President, Finance Conference Call Participants Kyle Bauser - Colliers Securities Matt Bullock - The Maxim Group Bruce Jackson - The Benchmark Company Ed Woo - Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2021 First Quarter Financial Results Conference Call. Today's conference is bei ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |----------------------------------------------------------------------------|--------------------------------------------------------------------| | For the transition | period from to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36385 BIOLASE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 87-0442441 (State or Other Jurisdiction of Incorpor ...

BIOLASE, Inc. (OTCQB:BIOL) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Todd Kehrli - EVC Group John Beaver - President and Chief Executive Officer Conference Call Participants Kyle Bauser - Colliers Securities Anthony Vendetti - Maxim Group Bruce Jackson - The Benchmark Company Ed Woo - Ascendiant Capital Operator Good day and welcome to the BIOLASE 2020 Fourth Quarter and Full Year Financial Results Conference Call. Today's conference is being recorded. At this time, I w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 BIOLASE, INC. (Exact name of registrant as specified in its charter) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36385 Delaware 87-0442441 (State or other jurisdiction of incorpo ...

BIOLASE, Inc. (OTCQB:BIOL) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Todd Kehrli - EVC Group Todd Norbe - President and Chief Executive Officer John Beaver - Executive Vice President, Chief Financial Officer and Chief Operating Officer Conference Call Participants Kyle Bauser - Colliers Securities Bruce Jackson - The Benchmark Group Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2020 Third Quarter Financial Re ...